• 1. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 2. Aluminium alkyl and aryloxide complexes of pyrazine and bipyridines: synthesis and structure?
  Doug Ogrin,Laura H. van Poppel,Simon G. Bott,Andrew R. Barron Dalton Trans., 2004, 3689-3694
• 3. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 4. Aggregation-induced chiral symmetry breaking of a naphthalimide–cyanostilbene dyad?
  Xin Li,Liangliang Zhu,Sai Duan,Yanli Zhao,Hans ?gren Phys. Chem. Chem. Phys., 2014,16, 23854-23860
• 5. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives
• Other Chemical Reagents

Introduction to (2S)-1-[(tert-butoxy)carbonyl]azetidine-2-carboxylic Acid (CAS No. 51077-14-6)

(2S)-1-[(tert-butoxy)carbonyl]azetidine-2-carboxylic acid, with the CAS number 51077-14-6, is a significant compound in the field of pharmaceutical chemistry and biomedicine. This compound belongs to the class of azetidine derivatives, which have garnered considerable attention due to their diverse biological activities and potential applications in drug development. The unique structural features of this molecule, particularly its stereochemistry and protective group, make it a valuable intermediate in synthetic chemistry and a promising candidate for further investigation in medicinal chemistry.

The stereochemistry of (2S)-1-[(tert-butoxy)carbonyl]azetidine-2-carboxylic acid is a critical aspect of its chemical properties. The (S)-configuration at the 2-position of the azetidine ring imparts specific interactions with biological targets, influencing its pharmacological activity. This stereochemical feature has been extensively studied in the context of enzyme inhibition and receptor binding, making it a key consideration in the design of novel therapeutic agents.

In recent years, there has been growing interest in the development of peptidomimetics, which are synthetic analogs of natural peptides designed to mimic their biological functions while offering improved pharmacokinetic properties. Azetidine derivatives, including (2S)-1-[(tert-butoxy)carbonyl]azetidine-2-carboxylic acid, have emerged as important scaffolds in this area due to their ability to mimic peptide backbone conformation and exhibit similar biological activities. The tert-butoxycarbonyl (Boc) group at the 1-position serves as an effective protecting group, facilitating selective modifications and enabling controlled synthesis of more complex molecules.

One of the most compelling applications of (2S)-1-[(tert-butoxy)carbonyl]azetidine-2-carboxylic acid is in the synthesis of protease inhibitors. Proteases are enzymes that play crucial roles in various physiological processes, including inflammation, blood clotting, and tumor cell growth. Inhibiting these enzymes has become a major strategy in drug development, with many successful drugs on the market targeting specific proteases. The azetidine ring in this compound can be modified to create inhibitors that selectively target particular proteases, offering potential therapeutic benefits.

Recent studies have highlighted the utility of (2S)-1-[(tert-butoxy)carbonyl]azetidine-2-carboxylic acid in the development of kinase inhibitors. Kinases are another class of enzymes that are frequently implicated in disease pathways, particularly cancer. By designing molecules that specifically inhibit kinase activity, researchers aim to disrupt these disease pathways and alleviate symptoms. The structural flexibility of azetidine derivatives allows for the creation of compounds that can bind to kinase active sites with high affinity and selectivity.

The protective group at the 1-position of (2S)-1-[(tert-butoxy)carbonyl]azetidine-2-carboxylic acid also plays a crucial role in its synthetic utility. The Boc group is stable under a wide range of conditions but can be selectively removed under mild acidic conditions, allowing for precise control over peptide synthesis. This feature makes it an ideal choice for constructing more complex molecules step-by-step, ensuring high yields and purity throughout the synthetic process.

In addition to its applications in drug development, (2S)-1-[(tert-butoxy)carbonyl]azetidine-2-carboxylic acid has shown promise in materials science. The unique structural properties of azetidine derivatives make them suitable for use as monomers or building blocks in polymer synthesis. These polymers can exhibit novel properties such as biodegradability or enhanced mechanical strength, opening up possibilities for applications in biomedical materials and sustainable technologies.

The biodegradability aspect is particularly relevant in today's focus on environmental sustainability. By developing polymers that can be easily broken down by natural processes, researchers aim to reduce waste and minimize environmental impact. Azetidine-based polymers offer a promising solution due to their ability to degrade into non-toxic byproducts while maintaining desirable material properties.

The versatility of (2S)-1-[(tert-butoxy)carbonyl]azetidine-2-carboxylic acid also extends to its use as a chiral building block in organic synthesis. Chiral molecules are non-superimposable mirror images of each other and are crucial for creating enantiomerically pure compounds, which often exhibit different biological activities depending on their stereochemistry. The (S)-configuration at the 2-position provides a reliable starting point for synthesizing enantiomerically enriched compounds using asymmetric catalysis or other chiral resolution techniques.

Asymmetric catalysis has seen significant advancements in recent years, enabling more efficient and selective transformations. By leveraging these techniques, researchers can produce enantiomerically pure forms of complex molecules with high yields and minimal side reactions. This capability is particularly important for pharmaceutical applications where enantiomeric purity can significantly impact drug efficacy and safety.

The protective group at the 1-position also facilitates cross-coupling reactions, which are essential for constructing complex molecular architectures. Cross-coupling reactions allow for the formation of carbon-carbon bonds between different organic fragments under mild conditions, making them invaluable tools in synthetic chemistry. By incorporating functional groups that participate in cross-coupling reactions into azetidine derivatives like (2S)-1-[(tert-butoxy)carbonyl]azetidine-2-carboxylic acid, researchers can extend their synthetic possibilities even further.

In conclusion, (2S)-1-[tert-butoxy]carbonyl]azetidine-2-carboxylic acid (CAS No. 51077-14-6) is a multifaceted compound with significant potential applications across various fields including pharmaceutical chemistry, materials science, and organic synthesis. Its unique structural features make it an invaluable intermediate for constructing complex molecules with diverse biological activities and material properties.

• 45170-31-8((2S)-2-[[(tert-Butoxy)carbonyl](methyl)amino]-3-methylbutanoic acid)
• 37784-17-1(N-Boc-D-proline)
• 13726-69-7(Boc-Hyp-OH)
• 98303-20-9(1-tert-butoxycarbonylpiperidine-2-carboxylic acid)
• 15761-39-4(Boc-L-Pro-OH)
• 59936-29-7(1-tert-butyl 2-methyl (2S)-pyrrolidine-1,2-dicarboxylate)
• 73323-65-6(1-tert-butyl 2-methyl (2R)-pyrrolidine-1,2-dicarboxylate)
• 1145-80-8(N-Carboxybenzyl-L-serine)
• 1152-62-1(Z-Met-OH)
• 1149-26-4(N-Cbz-L-valine)